Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed US-based Dr Caroline Popper, MBBS, MPH as Board Chair as part of its APAC clinical trials bioanalytics growth plans.
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed PhD and NHMRC Fellow Patrick Hughes as R&D Manager Immunobiology.
Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory based in Australia, announced a raft of new pharmacodynamics services for biotech and pharma clients conducting preclinical and clinical trials in Asia, US, EU and Australia.
Australia-based Agilex Biolabs announced a broad range of new pharmacodynamics services for biopharma clients running preclinical and clinical trials in the U.S., Asia, European Union and Australia.
One of the most important drug development start-up decisions is finding a centrally located bioanalytical laboratory that can support clinical research across all the study locations, and through pre-clinical then potentially for all Phases.
Quality control and consistency of sample management and analysis from early Phase onwards can make a real difference to quality of data and final outcomes.
Quality control and consistency of sample management and analysis from early Phase onwards can make a real difference to quality of data and final outcomes.
Australia-based Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory for global clients conducting preclinical and clinical trials, announced at AusBiotech 2019 today it has been selected as a Top 10 Bioanalytical Services Provider by PharmaTech Outlook Magazine (Booth #523).
Boston, MA – Agilex Biolabs, the Asia Pacific’s leading bioanalytical laboratory, announced...
Agilex Biolabs, Australia’s leading bioanalytical laboratory for global clients
conducting preclinical and clinical trials announced at DIA 2019 this week it will analyse more than 60,000 samples in 2019 (June 23-27 San Diego, CA) Booth 2006.
conducting preclinical and clinical trials announced at DIA 2019 this week it will analyse more than 60,000 samples in 2019 (June 23-27 San Diego, CA) Booth 2006.
"*" indicates required fields
